| The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases KJ Whitehead, AC Chan, S Navankasattusas, W Koh, NR London, J Ling, ... Nature medicine 15 (2), 177-184, 2009 | 398 | 2009 |
| Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the angioma alliance … A Akers, RAS Salman, IA Awad, K Dahlem, K Flemming, B Hart, H Kim, ... Neurosurgery 80 (5), 665-680, 2017 | 357 | 2017 |
| Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era J McDonald, W Wooderchak-Donahue, C VanSant Webb, K Whitehead, ... Frontiers in genetics 6, 126448, 2015 | 343 | 2015 |
| Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia ME Faughnan, JJ Mager, SW Hetts, VA Palda, K Lang-Robertson, ... Annals of internal medicine 173 (12), 989-1001, 2020 | 328 | 2020 |
| Cerebral cavernous malformations arise from endothelial gain of MEKK3–KLF2/4 signalling Z Zhou, AT Tang, WY Wong, S Bamezai, LM Goddard, R Shenkar, S Zhou, ... Nature 532 (7597), 122-126, 2016 | 287 | 2016 |
| Endothelial TLR4 and the microbiome drive cerebral cavernous malformations AT Tang, JP Choi, JJ Kotzin, Y Yang, CC Hong, N Hobson, R Girard, ... Nature 545 (7654), 305-310, 2017 | 283 | 2017 |
| Brain arteriovenous malformations MT Lawton, WC Rutledge, H Kim, C Stapf, KJ Whitehead, DY Li, T Krings, ... Nature reviews disease primers 1 (1), 1-20, 2015 | 281 | 2015 |
| Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations KJ Whitehead, NW Plummer, JA Adams, DA Marchuk, DY Li Oxford University Press for The Company of Biologists Limited 131 (6), 1437-1448, 2004 | 219 | 2004 |
| Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training SS Gounder, S Kannan, D Devadoss, CJ Miller, KS Whitehead, ... Public Library of Science 7 (9), e45697, 2012 | 203 | 2012 |
| Mechanistic Target of Rapamycin (Mtor) Is Essential for Murine Embryonic Heart Development and Growth Y Zhu, KMP Pires, KJ Whitehead, CD Olsen, B Wayment, YC Zhang, ... PloS one 8 (1), e54221, 2013 | 194 | 2013 |
| Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart SG Drakos, AG Kfoury, EH Hammond, BB Reid, MP Revelo, ... Journal of the American College of Cardiology 56 (5), 382-391, 2010 | 172 | 2010 |
| Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation CC Gibson, W Zhu, CT Davis, JA Bowman-Kirigin, AC Chan, J Ling, ... Circulation 131 (3), 289-299, 2015 | 169 | 2015 |
| The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression Z Zhou, DR Rawnsley, LM Goddard, W Pan, XJ Cao, Z Jakus, H Zheng, ... Developmental cell 32 (2), 168-180, 2015 | 158 | 2015 |
| Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice AC Chan, SG Drakos, OE Ruiz, ACH Smith, CC Gibson, J Ling, SF Passi, ... The Journal of clinical investigation 121 (5), 1871-1881, 2011 | 153 | 2011 |
| The netrin receptor UNC5B promotes angiogenesis in specific vascular beds S Navankasattusas, KJ Whitehead, A Suli, LK Sorensen, AH Lim, J Zhao, ... Oxford University Press for The Company of Biologists Limited 135 (4), 659-667, 2008 | 132 | 2008 |
| Effect of topical intranasal therapy on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia: a randomized clinical trial KJ Whitehead, NB Sautter, JP McWilliams, MM Chakinala, CA Merlo, ... Jama 316 (9), 943-951, 2016 | 104 | 2016 |
| Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy S Kannan, VR Muthusamy, KJ Whitehead, L Wang, AV Gomes, SE Litwin, ... Cardiovascular research 100 (1), 63-73, 2013 | 100 | 2013 |
| Endogenous endothelial cell signaling systems maintain vascular stability NR London, KJ Whitehead, DY Li Angiogenesis 12, 149-158, 2009 | 81 | 2009 |
| Evaluating strategies for the treatment of cerebral cavernous malformations DY Li, KJ Whitehead Stroke 41 (10_suppl_1), S92-S94, 2010 | 75 | 2010 |
| Atorvastatin treatment of cavernous angiomas with symptomatic hemorrhage exploratory proof of concept (AT CASH EPOC) trial SP Polster, A Stadnik, AL Akers, Y Cao, GA Christoforidis, MD Fam, ... Neurosurgery 85 (6), 843-853, 2019 | 71 | 2019 |
